Roivant Sciences (ROIV) Stock Forecast for 2023 – 2026. Sell or Buy Prediction

Roivant Sciences (ROIV) Stock Forecast for 2023 – 2026. Sell or Buy?

Updated: December 3, 2023 (09:16)

Sector: Healthcare

The share price of Roivant Sciences Ltd. (ROIV) now

What analysts predict: $15.56
52-week High/Low: $13.24 / $5.24

50/200 Day Moving Average: $9.75 / $9.61

This figure corresponds to the Average Price over the previous 50/200 days. For Roivant Sciences stocks, the 50-day moving average is the support level today.

For Roivant Sciences stocks, the 200-day moving average is the support level today.

Are you interested in Roivant Sciences Ltd. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Roivant Sciences stock price in 2023, 2024, 2025, 2026, 2027. How much will one Roivant Sciences share be worth in 2023 - 2027?

When should I take profit in Roivant Sciences stock? When should I record a loss on Roivant Sciences stock? What are analysts' forecasts for Roivant Sciences stock? What is the future of Roivant Sciences stock? We forecast Roivant Sciences stock performance using neural networks based on historical data on Roivant Sciences stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Roivant Sciences stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Roivant Sciences shares. This happens once a day.




Historical and forecast chart of Roivant Sciences stock

The chart below shows the historical price of Roivant Sciences stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Roivant Sciences stock price can be found in the table below.

Long-term forecasts by years.

Roivant Sciences Ltd. operates as a healthcare company. The Company offers investigational drugs in development for therapeutic areas such as dermatology, immunology, and respiratory diseases, as well as provides healthcare technologies which help healthcare institutions share and aggregate data. Roivant Sciences provides services worldwide.

Roivant Sciences daily forecast for a month

Date Target Pes. Opt. Vol., %
Dec 05 9.76 9.63 10.04 4.31
Dec 06 9.95 9.64 10.17 5.58
Dec 07 9.63 9.44 9.81 3.93
Dec 08 9.35 9.16 9.72 6.18
Dec 09 9.15 9.02 9.35 3.65
Dec 10 9.52 9.32 9.82 5.42
Dec 11 9.52 9.34 9.80 4.94
Dec 12 9.44 9.10 9.70 6.59
Dec 13 9.33 9.07 9.64 6.22
Dec 14 8.96 8.78 9.30 5.92
Dec 15 8.71 8.51 8.97 5.42
Dec 16 8.84 8.53 9.03 5.91
Dec 17 9.06 8.88 9.31 4.90
Dec 18 8.89 8.72 9.21 5.71
Dec 19 9.23 9.05 9.34 3.16
Dec 20 9.27 8.91 9.60 7.75
Dec 21 9.59 9.42 9.94 5.50
Dec 22 9.98 9.82 10.17 3.55
Dec 23 10.04 9.91 10.27 3.60
Dec 24 10.00 9.80 10.22 4.23
Dec 25 9.78 9.60 10.04 4.58
Dec 26 9.30 9.08 9.58 5.48
Dec 27 9.46 9.28 9.72 4.69
Dec 28 9.30 9.01 9.58 6.35
Dec 29 9.65 9.33 9.81 5.12
Dec 30 9.77 9.54 9.88 3.58
Dec 31 9.66 9.43 9.87 4.61
Jan 01 9.32 9.15 9.53 4.18
Jan 02 8.93 8.62 9.28 7.56
Jan 03 8.87 8.62 9.16 6.28

Roivant Sciences Daily Price Targets


Roivant Sciences Stock Forecast 12-05-2023.

Forecast target price for 12-05-2023: $9.76.
Negative dynamics for Roivant Sciences shares will prevail with possible volatility of 4.129%.
Pessimistic target level: 9.63
Optimistic target level: 10.04

Roivant Sciences Stock Forecast 12-06-2023.

Forecast target price for 12-06-2023: $9.95.
Positive dynamics for Roivant Sciences shares will prevail with possible volatility of 5.281%.
Pessimistic target level: 9.64
Optimistic target level: 10.17

Roivant Sciences Stock Forecast 12-07-2023.

Forecast target price for 12-07-2023: $9.63.
Negative dynamics for Roivant Sciences shares will prevail with possible volatility of 3.778%.
Pessimistic target level: 9.44
Optimistic target level: 9.81

Roivant Sciences Stock Forecast 12-08-2023.

Forecast target price for 12-08-2023: $9.35.
Negative dynamics for Roivant Sciences shares will prevail with possible volatility of 5.817%.
Pessimistic target level: 9.16
Optimistic target level: 9.72

Roivant Sciences Stock Forecast 12-09-2023.

Forecast target price for 12-09-2023: $9.15.
Negative dynamics for Roivant Sciences shares will prevail with possible volatility of 3.524%.
Pessimistic target level: 9.02
Optimistic target level: 9.35

Roivant Sciences Stock Forecast 12-10-2023.

Forecast target price for 12-10-2023: $9.52.
Positive dynamics for Roivant Sciences shares will prevail with possible volatility of 5.138%.
Pessimistic target level: 9.32
Optimistic target level: 9.82

ROIV (ROIV) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Dec. 9.73 8.79 10.29 14.62

Roivant Sciences forecast for this year


Roivant Sciences Stock Prediction for Dec 2023

An downtrend is forecast for this month with an optimal target price of $9.73464. Pessimistic: $8.79. Optimistic: $10.29



Roivant Sciences (ROIV) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 10.42 9.31 10.76 13.50
Mar 11.08 10.41 11.56 9.92
Mar 11.24 10.03 11.90 15.73
Apr 9.64 8.54 10.39 17.81
May 10.18 9.23 10.62 13.08
Jun 9.54 8.93 9.84 9.16
Jul 9.05 8.32 9.51 12.56
Aug 8.85 8.43 9.20 8.36
Sep 8.25 7.99 8.63 7.45
Oct 8.87 7.92 9.41 15.83
Nov 7.98 7.56 8.51 11.24
Dec 7.41 7.19 7.96 9.64

Roivant Sciences (ROIV) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 7.37 7.02 7.67 8.51
Mar 7.04 6.58 7.39 10.86
Mar 7.89 7.21 8.32 13.38
Apr 7.62 7.35 8.20 10.45
May 7.78 6.92 8.40 17.65
Jun 8.61 7.98 9.64 17.28
Jul 9.14 8.06 9.77 17.54
Aug 9.74 9.03 10.15 11.08
Sep 9.54 8.44 10.22 17.49
Oct 9.79 9.35 10.54 11.29
Nov 9.37 8.69 10.23 14.98
Dec 9.45 8.60 10.36 16.97

Roivant Sciences (ROIV) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 9.54 9.21 10.15 9.30
Mar 10.45 9.67 11.17 13.47
Mar 11.16 9.95 12.33 19.28
Apr 11.16 10.36 12.03 13.92
May 11.71 11.18 12.26 8.74
Jun 12.13 10.73 12.77 15.96
Jul 13.22 11.98 14.34 16.47
Aug 14.06 13.09 14.80 11.54
Sep 15.81 14.95 16.90 11.51
Oct 14.81 13.48 15.35 12.16
Nov 15.77 14.23 16.81 15.34
Dec 15.15 13.81 15.74 12.27

Roivant Sciences (ROIV) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 14.63 13.64 15.60 12.52
Mar 15.97 15.27 17.29 11.64
Mar 14.87 14.00 15.94 12.17
Apr 15.51 15.00 16.84 10.92
May 14.72 13.35 15.50 13.82
Jun 13.75 12.74 15.28 16.61
Jul 13.69 12.13 15.06 19.49
Aug 15.37 14.36 16.73 14.19
Sep 17.63 16.81 18.56 9.41
Oct 19.30 18.05 21.50 16.02
Nov 19.76 17.54 20.44 14.21
Dec 18.75 17.01 20.64 17.58

Roivant Sciences information and performance

Roivant Sciences Address

CLARENDON HOUSE, 2 CHURCH STREET, HAMILTON HM11, BM

Market Capitalization: 7 307 642 000 $

Market capitalization of the Roivant Sciences Ltd. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ROIV shares in the company outstanding by the market price of one share.

EBITDA: -1 018 380 992 $

EBITDA of Roivant Sciences is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -1.47

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 1.96
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 62.02

Enterprise Value (EV) /Revenue

EV To EBITDA: -5.53

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 803921000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.